Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers

NCT03162510 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer in Situ
Pancreatic Cancers
Biliary Cancers

Interventions

DRUG: Oxaliplatin
DRUG: Albumin-Bound Paclitaxel /nab-Paclitaxel
DRUG: S-1
DRUG: LV

Sponsor

National Health Research Institutes, Taiwan

Collaborators

[object Object]
[object Object]